Positive news
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @CrisBonorino: First human trial of a #COVID19 vaccine https://t.co/L7Atdn35tV
RT @CrisBonorino: First human trial of a #COVID19 vaccine
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
First human trial of a #COVID19 vaccine
RT @pedrourdebienes: Una buena noticia para un Viernes
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
An exciting step in the right direction!
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
It’s a good start. (There is a hell of a long way to go yet and no one should underestimate the enormous challenge of scaling up to mass manufacture. ) @BioProcessIntl #COVID-19
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
I’m STILL related but unrelated news!! #COVID19 #coronavirus #coronavirusvaccine
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @pedrourdebienes: Una buena noticia para un Viernes
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
Una buena noticia para un Viernes
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @acinnacional: Actualmente se realiza seguimiento a largo plazo de los voluntarios y se está realizando un estudio fase II. https://t.co…
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored #COVID19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial @TheLancet 👉https://t.co/lEybUmNjhE https://t.co/ocN0kroDKX
Promising Vaccine against covid-19 🤞 https://t.co/WIEM47d65N
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @MonsieurQFB: @UNAM_MX Aquí también hice la mención 🙌🏽 https://t.co/kg9jjbHjWf
RT @MonsieurQFB: @UNAM_MX Aquí también hice la mención 🙌🏽
RT @MonsieurQFB: @UNAM_MX Aquí también hice la mención 🙌🏽
@UNAM_MX Aquí también hice la mención 🙌🏽
Safety, Tolerability, and Immunogenicity of a Recombinant Adenovirus type-5 Vectored COVID-19 Vaccine: A Dose-Escal… https://t.co/olrthmkPvX
RT @acinnacional: Actualmente se realiza seguimiento a largo plazo de los voluntarios y se está realizando un estudio fase II. https://t.co…
RT @acinnacional: Actualmente se realiza seguimiento a largo plazo de los voluntarios y se está realizando un estudio fase II. https://t.co…
Actualmente se realiza seguimiento a largo plazo de los voluntarios y se está realizando un estudio fase II. https://t.co/wdaE89EuRe
RT @Magrelopez: Vacuna recombinante contra #COVIDー19 comienza a mostrar respuesta inmunológica protectora. Hay varios desarrollos con difer…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
Good Developments on the #covid-19 vaccins
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial https://t.co/VMsTAIllZ8
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
Results of first human trial of Sars-Cov-2 vaccine show promising results from Phase 1: https://t.co/u2eygq7aR6
RT @AUBMCED: Many different vaccines, with a variety of pros and cons are in rapid development.This first-in-human trial of Ad5 vectored CO…
RT @_urauratantan_: LANCETでも報告されている、こんなのが見つかりました 2020/5/22公開 中国でも「組換えアデノウイルス5型ベクターCOVID-19ワクチンの安全性、忍容性、および免疫原性:用量漸増、非盲検、非ランダム化、ヒトでの最初の試験」…
Many different vaccines, with a variety of pros and cons are in rapid development.This first-in-human trial of Ad5 vectored COVID-19 vaccine shows it was tolerable and immunogenic in healthy adults making it worth investigating further. https://t.co/dJoHka
RT @YAYshamsaldeen: البعض يستنكر جملة "التطعيم ياخذ وقت" 💡اعتماد التطعيم يبنى على ✅المأمونية ✅الفاعلية ➕ ⚠️✅استمرارية الفاعلية✅⚠️ قد يكو…
RT @YAYshamsaldeen: 💉🧬تطعيم Ad5 vectored COVID-19 متقدم زمنيا على كل التطعيمات السابقة ✅المرحلة الإكلينيكية الأولى (المأمونية) تمّت ونشرت…
LANCETでも報告されている、こんなのが見つかりました 2020/5/22公開 中国でも「組換えアデノウイルス5型ベクターCOVID-19ワクチンの安全性、忍容性、および免疫原性:用量漸増、非盲検、非ランダム化、ヒトでの最初の試験」 https://t.co/ndFTQVW7xJ
RT @pmanickam: First human trial of #COVID19 vaccine among 108 adults finds it is safe & produced neutralising antibodies & T-cell respons…
RT @AssalaLamaa: @THEkingKJU @cgtnarabic هنا الدراسة:https://t.co/D97YUygZb4
@THEkingKJU @cgtnarabic هنا الدراسة:https://t.co/D97YUygZb4
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @KoffiSodokin: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation,…
RT @KoffiSodokin: "Funding: National Key R&D Program of China, National Science and Technology Major Project, and CanSino Biologics". https…
RT @KoffiSodokin: "Interpretation The Ad5 vectored COVID-19 vaccine is tolerable and immunogenic at 28 days post-vaccination. Humoral respo…
RT @KoffiSodokin: Between March 16 and March 27, 2020, we screened 195 individuals for eligibility. Of them, 108 participants (51% male, 49…
RT @KoffiSodokin: En gros, on trouve dans cette étude, des résultats d'espoir pour un vaccin testé entre le 16 et le 27 mars 2020 en Chine…